about
Obsessive-compulsive disorder and related disorders: a comprehensive surveySwitching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case seriesA systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulationAdjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label studySuicide during Perinatal Period: Epidemiology, Risk Factors, and Clinical CorrelatesCelecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On TrialsPrevalence and clinical features associated with bipolar disorder polypharmacy: a systematic reviewThe Interface between Neuroscience and Neuro-Psychoanalysis: Focus on Brain ConnectivityAtypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical TrialsLisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trialsAgomelatine beyond borders: current evidences of its efficacy in disorders other than major depressionMedicine and psychiatry in Western culture: Ancient Greek myths and modern prejudicesHow common is bipolar disorder in general primary care attendees? A systematic review and meta-analysis investigating prevalence determined according to structured clinical assessments.Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management.Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic ReviewsSafety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Obsessive-compulsive aspects and pathological gambling in an Italian sample.Current nosology of treatment resistant depression: a controversy resistant to revisionAβ1-42 monomers or oligomers have different effects on autophagy and apoptosisAdding 5-hydroxytryptamine receptor type 3 antagonists may reduce drug-induced nausea in poor insight obsessive-compulsive patients taking off-label doses of selective serotonin reuptake inhibitors: a 52-week follow-up case reportA Case of Treatment Resistant Depression and Alcohol Abuse in a Person with Mental Retardation: Response to Aripiprazole and Fluvoxamine Therapy upon Consideration of a Bipolar Diathesis after Repetitive Failure to Respond to Multiple AntidepressantAre atypical depression, borderline personality disorder and bipolar II disorder overlapping manifestations of a common cyclothymic diathesis?Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation.Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants.New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine.Psychopathological aspects of kidney transplantation: Efficacy of a multidisciplinary team.Prevalence and diagnostic distribution of medically unexplained painful somatic symptoms across 571 major depressed outpatientsThe prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis.Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives.An update of safety of clinically used atypical antipsychotics.Immunomodulation Mechanism of Antidepressants: Interactions between Serotonin/Norepinephrine Balance and Th1/Th2 BalanceSuccessful ziprasidone monotherapy in a case of delusional parasitosis: a one-year followup.The Relationships between Cholesterol and Suicide: An Update.The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report.The relationship between drive to thinness, conscientiousness and bulimic traits during adolescence: a comparison between younger and older cases in 608 healthy volunteersCatatonia: a narrative review.Could the underestimation of bipolarity obstruct the search for novel antidepressant drugs?The argument of antidepressant drugs in the treatment of bipolar depression: mixed evidence or mixed states?
P50
Q21203920-55926C70-4493-4221-A2C0-CA7F6AAA7C6FQ21203936-99A7AE54-1DD8-483B-90CB-1C731C3AFA16Q22305782-C289C998-BE7A-43B3-BFAE-75854D2174F8Q24619584-359B32D8-53D2-4020-A755-332A696A4596Q26738486-38355775-ED70-42BD-8676-86379B0D43B7Q26741541-106BD283-DB72-475A-B150-09E9E63D7D6CQ26751363-3AEC8123-40E8-4D30-9C4D-EE3F000C75B8Q26766496-39584DEF-AFBD-4C50-BD1B-F38A0597D5F7Q28074759-91457C58-3B45-4ABC-A71F-CE6B84C2342DQ28553322-CC87722A-53FB-4DA9-BE5A-3C8BE5D48707Q28651498-DAD072F3-C636-437D-821A-73EA2364B09BQ28750488-6F6FCC4A-6ABC-4080-8319-AB07378D0924Q30251969-FBBB1131-0838-4D0E-95FA-825DEFC1F7CCQ30480531-23293E08-AF60-4E7B-B534-BC4012D56444Q33685314-6C43C389-E700-4C0F-9F7F-9B9777432FFDQ33716263-CAFF918F-F192-41E3-9BF1-2C2CF6445387Q33878816-4459A0E1-B8BD-464C-A499-91ACB65B59C1Q33892948-AEB7AF0B-2D24-4003-8DC7-D35E742838CFQ33920910-1E5DAF76-3774-47E6-8AF2-52250CD3D0C6Q34344718-00DE7776-D3CC-4CB4-A64F-DFAE50D72D11Q34419374-A038E812-8865-4895-8650-66840025B673Q34521320-B809A1B5-A924-4A6B-A43D-A0F6C5C757D3Q34623377-4B90FAD1-F8B4-4314-9BF1-90980D35A322Q34664605-06A6B2AE-3893-4918-86A0-04E4606741E1Q34666782-F38B6EC4-7D30-443B-AE80-2C8C4E3E8923Q34676776-D1AA6F71-BD93-4F6B-92C0-40E25A21DA8DQ34761356-0D0D66AA-046D-4119-9092-A3237D9AE7B9Q34956421-4FF62088-A808-4060-9095-386116DA0938Q35924763-8A33FE29-9275-4E0A-B990-B9FDCE785335Q35995252-DF27FC65-C7C4-43CD-B5E6-1A58C04BBEF2Q36062184-9F3C6B84-7F8B-435D-83DD-0E922B647552Q36067334-60393E4F-F39F-479F-BE5E-48E85AF62F14Q36896209-27759451-DD1F-4EE5-A81A-771BD2655D8DQ36900141-211E57F3-B101-497B-AFCE-E511FCA4D008Q37007350-6097F75F-F3D4-41CD-8C97-6E7536087B61Q37052408-9150D134-0405-4802-9E0F-962209B25D3CQ37275391-0724A288-476D-4D45-9EED-CA235158F387Q37835856-DF837F86-451A-4120-A27C-B74C58D7AE5CQ37958033-F626EC4B-CEB1-4864-9985-9B17660374CAQ38040453-F92D3D95-7BF1-485E-98DA-C88A71AE3E86
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michele Fornaro
@ast
Michele Fornaro
@en
Michele Fornaro
@es
Michele Fornaro
@nl
Michele Fornaro
@sl
type
label
Michele Fornaro
@ast
Michele Fornaro
@en
Michele Fornaro
@es
Michele Fornaro
@nl
Michele Fornaro
@sl
prefLabel
Michele Fornaro
@ast
Michele Fornaro
@en
Michele Fornaro
@es
Michele Fornaro
@nl
Michele Fornaro
@sl
P106
P1153
7004222751
P2038
Michele_Fornaro4
P21
P2798
P31
P496
0000-0002-9647-0853
P569
2000-01-01T00:00:00Z